Patterns of pregabalin use, misuse, and dependence: Insights from an addiction treatment center
Authors:
Open Access
- 25 September 2026
- journal article
- Published by Scientific Scholar in Journal of Neurosciences in Rural Practice
- Vol. 17 (3) , 479-484
Abstract
Pregabalin misuse is increasingly reported among individuals with substance use disorders (SUDs), but Indian data are scarce. This study aimed to estimate the prevalence and patterns of pregabalin use among treatment-seeking individuals with SUDs and examine their clinical and demographic characteristics. We conducted a cross-sectional study at a specialized addiction treatment facility in Northern India (July–December 2024). Treatment-seeking patients were screened, and data were collected through structured clinical interviews covering demographics, substance use, reasons for pregabalin use, withdrawal symptoms, and adverse effects. Among 2031 consecutively screened, treatment-seeking patients aged ≥15 years, 165 (8.1%; 95% confidence interval [CI] 6.9–9.4) reported pregabalin use within the past three months. Users were predominantly male (98.2%) with a mean age of 28.4 years. Opioid use was highly prevalent (98.2%), and 33.3% reported intravenous opioid use. Pregabalin was obtained mainly via chemists (45.5%) and friends/peers (38.7%). Dependence was identified in 61.8% patients. The mean daily dose was 1176 mg, indicating frequent supratherapeutic use. Common motivations included euphoria (25.5%), opioid substitution (23%), and withdrawal relief (21.2%). Withdrawal symptoms were reported by 74.5%. These findings highlight clinically significant pregabalin misuse, particularly among opioid-dependent patients, underscoring the need for improved screening and regulatory vigilance.Keywords
This publication has 11 references indexed in Scilit:
- Pregabalin Use/Misuse: A Source of Consternation in Western PunjabIndian Journal of Psychological Medicine, 2022
- A case of pregabalin addictionIndustrial Psychiatry Journal, 2021
- Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature reviewNeuropsychopharmacology Reports, 2021
- Preliminary Evidence of Pregabalin Misuse among Prescription and/or Illicit Opioid (Mis)usersJournal of Psychoactive Drugs, 2020
- Pregabalin: A range of misuse‐related unanswered questionsCNS Neuroscience & Therapeutics, 2019
- Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisoningsAddiction, 2018
- Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factorsDrug and Alcohol Dependence, 2018
- How addictive are gabapentin and pregabalin? A systematic reviewEuropean Neuropsychopharmacology, 2017
- Risk to heroin users of polydrug use of pregabalin or gabapentinAddiction, 2017
- Abuse and Misuse of Pregabalin and GabapentinDrugs, 2017